$XPO stock is up 10% today. Here's what we see in our data.

$XPO stock has now risen 10% today, according to our price data from Polygon. There has been approximately $251,553,268 of trading volume.

It has been the 348th most-searched ticker on Quiver Quantitative over the last day, out of 9,893 total tickers searched.

Here is what we see in our data on $XPO (you can track the company live on Quiver's $XPO stock page):

$XPO Insider Trading Activity

$XPO insiders have traded $XPO stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $XPO stock by insiders over the last 6 months:

ALLISON LANDRY sold 3,250 shares for an estimated $438,869

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$XPO Hedge Fund Activity

We have seen 245 institutional investors add shares of $XPO stock to their portfolio, and 254 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

INVESCO LTD. added 3,945,683 shares (+306.9%) to their portfolio in Q2 2025, for an estimated $498,300,306
DURABLE CAPITAL PARTNERS LP added 1,589,759 shares (+79.3%) to their portfolio in Q2 2025, for an estimated $200,770,664
COOKE & BIELER LP added 856,898 shares (+inf%) to their portfolio in Q2 2025, for an estimated $108,217,648
JPMORGAN CHASE & CO removed 832,309 shares (-50.9%) from their portfolio in Q2 2025, for an estimated $105,112,303
ALLIANCEBERNSTEIN L.P. removed 632,702 shares (-76.1%) from their portfolio in Q2 2025, for an estimated $79,903,935
AMERICAN CENTURY COMPANIES INC removed 614,911 shares (-95.2%) from their portfolio in Q2 2025, for an estimated $77,657,110
BLACKROCK, INC. removed 588,346 shares (-4.8%) from their portfolio in Q2 2025, for an estimated $74,302,216

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$XPO Congressional Stock Trading

Members of Congress have traded $XPO stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $XPO stock by members of Congress over the last 6 months:

REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 07/22 and 1 sale worth up to $15,000 on 08/04.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$XPO Analyst Ratings

Wall Street analysts have issued reports on $XPO in the last several months. We have seen 12 firms issue buy ratings on the stock, and 1 firms issue sell ratings.

Here are some recent analyst ratings:

Stifel issued a "Buy" rating on 10/28/2025
Raymond James issued a "Outperform" rating on 10/14/2025
Benchmark issued a "Buy" rating on 10/01/2025
Evercore ISI Group issued a "Outperform" rating on 09/30/2025
Citigroup issued a "Buy" rating on 08/01/2025
Wells Fargo issued a "Overweight" rating on 08/01/2025
Morgan Stanley issued a "Underweight" rating on 08/01/2025

To track analyst ratings and price targets for $XPO, check out Quiver Quantitative's $XPO forecast page.

$XPO Price Targets

Multiple analysts have issued price targets for $XPO recently. We have seen 16 analysts offer price targets for $XPO in the last 6 months, with a median target of $144.5.

Here are some recent targets:

J. Bruce Chan from Stifel set a target price of $140.0 on 10/28/2025
Patrick Tyler Brown from Raymond James set a target price of $150.0 on 10/14/2025
Ariel Rosa from Citigroup set a target price of $155.0 on 10/13/2025
Brian Ossenbeck from JP Morgan set a target price of $144.0 on 10/08/2025
Ravi Shanker from Morgan Stanley set a target price of $83.0 on 10/06/2025
Thomas Wadewitz from UBS set a target price of $162.0 on 10/03/2025
Christopher Kuhn from Benchmark set a target price of $140.0 on 10/01/2025

You can track data on $XPO on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.